UPDATE : Saturday, March 24, 2018
Nature Cell expects to receive conditional approval for Jointstem
Nature Cell showed confidence in obtaining conditional approval for Jointst...
by Lee Han-soo  |  2017-12-19 18:22
‘Celltrion’s annual revenue to top ₩3 trillion in 5 years’
Celltrion, which recently obtained Europe’s approval for breast cancer trea...
by Nam Doo-hyun  |  2017-12-18 15:55
Samsung Bioepis, Daewoong sign exclusive supply contract for Samfenet
Samsung Bioepis and Daewoong Pharmaceuticals have signed an exclusive suppl...
by Lee Han-soo  |  2017-12-18 10:59
Corestem’s NeuroNata-R marks increase in foreign patients
The number of foreign patients visiting Korea to use Corestem’s NeuroNata-R...
by Lee Han-soo  |  2017-12-15 16:22
FDA approves Pfizer’s Remicade biosimilar
Pfizer said Wednesday that it received U.S. Food and Drug Administration’s ...
by Lee Han-soo  |  2017-12-14 17:16
Samsung BioLogics’ 2nd factory gets European approval
Samsung BioLogics said Thursday that its second factory received manufactur...
by Lee Han-soo  |  2017-12-14 10:52
‘Surge of gene-therapy providing hospitals to benefit Invossa’
With hospitals increasingly registering as a provider of gene therapies, Ko...
by Nam Doo-hyun  |  2017-12-12 15:59
PCL shares rise despite regulator’s warning
Shares of PCL, a provider of in vitro diagnostic products, have risen again...
by Nam Doo-hyun  |  2017-12-12 11:02
Oscotec shares rebound on launch of US clinical trial
Shares of Oscotec rebounded on Monday on the company’s announcement that it...
by Nam Doo-hyun  |  2017-12-11 15:50
ToolGen’s shares jump on gene therapy market expectations
With rising expectations for a rapid growth of gene therapy market, investo...
by Nam Doo-hyun  |  2017-12-11 15:16
MGmed to run world’s 1st postmortem DNA bank
MGmed, a Korean firm specializing in molecular diagnostic techniques for ge...
by Marian Chu  |  2017-12-08 17:11
Toolgen wins German utility model for gene editing tool
Toolgen said Friday that it has completed the registration of two German ut...
by Lee Han-soo  |  2017-12-08 16:56
Celltrion seeks to shift to main bourse
Biosimilar maker Celltrion is aiming to relist its stocks on the Korea Exch...
by Lee Han-soo  |  2017-12-07 11:25
Medipost wins patent for Cartistem in Europe
Medipost said Wednesday that it has acquired patents on its core production...
by Lee Han-soo  |  2017-12-06 13:15
MGmed emerges as largest shareholder of UK bio venture
MGmed said it has emerged as the largest stakeholder of Oxford Vacmedix (OV...
by Marian Chu  |  2017-12-06 13:00
Kolon Life Science confident to make Invossa global blockbuster
Despite proved efficacy in reducing pain for osteoarthritis patients, Kolon...
by Nam Doo-hyun  |  2017-12-06 09:30
ViroMed starts trial on VM202’s effect on peripheral artery disease
VM BioPharma, the U.S subsidiary of ViroMed, announced Tuesday that it has ...
by Lee Han-soo  |  2017-12-05 15:40
Shares of biotech firms, listed with ‘exceptional techs,’ rise above offer price
Most of the biotechnology companies, listed on Kosdaq early this year under...
by Nam Doo-hyun  |  2017-12-05 14:38
Sewon seeks p3 clinical trials for cartilage cell therapy in Japan
Sewon Cellontech said Monday that Olympus RMS has submitted phase 3 clinica...
by Lee Han-soo  |  2017-12-04 16:17
Cord blood biotech firms enjoy stock price gains this year
Korean biotech firms with major pipelines in cord blood banks and umbilical...
by Nam Doo-hyun  |  2017-12-04 15:02
Back to Top